| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
0.845 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
0.845 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.845 |
Evidence |
|
| CP |
CP: Ceruloplasmin precursor |
MGP |
MGP, MGLAP, GIG36: Matrix Gla protein precursor |
0.845 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
RHO |
RHO, OPN2: Rhodopsin |
0.845 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
0.845 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.845 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.845 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
0.845 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
0.845 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.845 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
0.845 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
0.845 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.845 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.845 |
Evidence |
|
| RELB |
RELB: Transcription factor RelB |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
0.84 |
Evidence |
O
|
| GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
RUVBL1 |
RUVBL1, NMP238, TIP49, TIP49A: RuvB-like 1 |
0.84 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
HYAL2 |
HYAL2, LUCA2: Hyaluronidase-2 precursor |
0.84 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
CCND2 |
CCND2: G1/S-specific cyclin-D2 |
0.84 |
Evidence |
|
| EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
0.84 |
Evidence |
|
| GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.84 |
Evidence |
|
| CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
0.84 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.84 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
0.84 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.84 |
Evidence |
|